BIOCEPT INC (BIOC)
US09072V6002 - Common Stock
| MRQ (2023-6-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 6.63M | 12.90M | 28.86M | 14.37M | 9.30M | |||
| Cash Equivalents | N/A | N/A | N/A | N/A | N/A | |||
| Receivables | 800.00K | 2.15M | 13.79M | 14.14M | 3.53M | |||
| Inventories | 551.00K | 757.00K | 2.65M | 1.93M | 770.00K | |||
| Other Current Assets | 876.00K | 538.00K | 391.00K | 2.15M | 300.00K | |||
| Total Current Assets | 8.86M | 16.34M | 45.69M | 32.59M | 13.89M | |||
| Non-Current Assets | ||||||||
| PPE Net | 12.86M | 14.14M | 14.27M | 14.43M | 3.84M | |||
| Other Non-Current Assets | 386.00K | 386.00K | 456.00K | 430.00K | N/A | |||
| Total Non-Current Assets | 13.24M | 14.53M | 14.72M | 14.86M | 3.84M | |||
| TOTAL ASSETS | 22.10M | 30.87M | 60.42M | 47.45M | 17.73M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 526.00K | 117.00K | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 815.00K | 1.10M | 1.08M | 960.00K | 720.00K | |||
| Accrued Expenses | 2.09M | 2.77M | 3.44M | 3.17M | 2.82M | |||
| Accounts Payable | 1.47M | 1.52M | 7.25M | 8.36M | 2.01M | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | 0.00 | |||
| Total Current Liabilities | 4.90M | 5.51M | 11.77M | 12.49M | 5.56M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 836.00K | 1.20M | 1.43M | 1.46M | 970.00K | |||
| Other Non-Current Liabilities | 16.07M | 15.31M | 9.74M | 9.81M | 0.00 | |||
| Total Non-Current Liabilities | 16.91M | 16.51M | 11.16M | 11.27M | 970.00K | |||
| TOTAL LIABILITIES | 21.81M | 22.01M | 22.94M | 23.76M | 6.53M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -309.21M | -298.44M | -266.35M | -263.53M | -245.72M | |||
| Additional Paid In Capital | 309.50M | 307.30M | 303.83M | 287.22M | 256.91M | |||
| Common Shares | 240.00 | 2.00K | 2.00K | 0.00 | 10.00K | |||
| Other Shareholders' Equity | -240.00 | N/A | N/A | N/A | N/A | |||
| Shares Outstanding | 2.41M | 568.95K | 561.60K | 13.40M | 5.47M | |||
| Tangible Book Value per Share | 0.12 | 15.57 | 66.74 | 1.77 | 2.05 | |||
| Total Shareholders' Equity | 290.00K | 8.86M | 37.48M | 23.69M | 11.20M | |||
| TOTAL LIABILITIES AND EQUITY | 22.10M | 30.87M | 60.42M | 47.45M | 17.73M | |||
| Statistics | ||||||||
| Debt/Equity | 4.70 | 0.15 | 0.04 | 0.06 | 0.09 | |||
| Current Ratio | 1.81 | 2.97 | 3.88 | 2.61 | 2.50 | |||
| Return On Assets (ROA) | -239.73% | -103.93% | -4.67% | -37.53% | -142.47% | |||
| Return On Equity (ROE) | -18271.38% | -362.16% | -7.53% | -75.18% | -225.54% | |||
All data in USD